跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 150 条关于
“postinflammatory hyperpigmentation”
全部
150
临床试验
113
药物
3
机构
0
资讯
34
去年
Triple-Combination Acne Gel Shows Efficacy and Safety in Hispanic Patients and Long-Term Use
2个月前
Unexplained Skin Darkening Leads to Life-Saving Addison's Disease Diagnosis in 24-Year-Old Woman
2年前
Hypofractionated Radiation Therapy Improves Outcomes in Breast Cancer Patients
12个月前
Landmark Clinical Trials Demonstrate Efficacy of IL-13 and IL-4/IL-13 Inhibitors in Patients with Darker Skin Tones
2年前
Afamelanotide Under Evaluation for Vitiligo Treatment in Phase 3 Trial
10个月前
Rhythm Pharmaceuticals Secures Public Reimbursement for IMCIVREE in Five Canadian Provinces
去年
Rhythm Pharmaceuticals Regains Global Control of IMCIVREE by Reacquiring Rights in China
去年
Setmelanotide Receives Orphan Drug Designation in Japan for Hypothalamic Obesity Treatment
去年
Journey Medical's Emrosi Receives FDA Approval for Rosacea Treatment
去年
Setmelanotide Shows Promise in Reducing Obesity in Young Children With Rare Genetic Deficiencies
第 1 页，共 4 页
上一页
下一页
